BE641707A - - Google Patents

Info

Publication number
BE641707A
BE641707A BE641707DA BE641707A BE 641707 A BE641707 A BE 641707A BE 641707D A BE641707D A BE 641707DA BE 641707 A BE641707 A BE 641707A
Authority
BE
Belgium
Prior art keywords
water
desc
page number
clms page
mono
Prior art date
Application number
Other languages
English (en)
French (fr)
Publication of BE641707A publication Critical patent/BE641707A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0495—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE641707D BE641707A (enExample)

Publications (1)

Publication Number Publication Date
BE641707A true BE641707A (enExample)

Family

ID=204754

Family Applications (1)

Application Number Title Priority Date Filing Date
BE641707D BE641707A (enExample)

Country Status (1)

Country Link
BE (1) BE641707A (enExample)

Similar Documents

Publication Publication Date Title
JPS60243017A (ja) 抗けいれん組成物
DE60031705T2 (de) Salicylamid-derivate
CH695862A5 (fr) Forme cristalline I de la methyl-4-(4-methyl-1-piperazinyl) 10H-thieno [2,3-b] [1,5] benzodiazepine.
JPS62500872A (ja) 新規なアゾ化合物
CA1072567A (en) Oxazolidinones, a process for their production and medicaments containing these compounds
MC1156A1 (fr) Composes cycliques
US4112089A (en) 4-Substituted-1,3-dithiolan-2-ylidene malonates and pharmaceutical compositions containing the same
MC2135A1 (fr) Carboxamides aromatiques
US4304785A (en) Dilignols and dilignol-type compounds
EP0015214A1 (fr) Nouveaux dérivés de benzoyl-2 glycylanilides substitués, leur préparation et leur application en tant que médicaments anxiolytiques
CA1082716A (fr) Procede de preparation de nouveaux derives de 5- thiazole methane amine
DE69526413T2 (de) Heterocyclische Carboxyalkylderivate
JPS5951282A (ja) イミノピロリジニルインド−ルの製法
LU86405A1 (fr) Derive antipsychotique du benzisothiazole s-oxyde
EP0022017B1 (fr) Nouveaux dérivés de benzoyl-2 nitro-4 anilides, leur préparation et leur application en tant que médicaments
CH642663A5 (de) 3,7-disubstituierte 3-cephem-4-carbonsaeure-verbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel.
MC1036A1 (fr) Procédé de préparation de composés de mercaptopyrrole condensés
EP0382635B1 (fr) Utilisation de dérivés d'alkyl-5 pyridazine comme médicaments actifs sur le système cholinergique
WO1999021831A1 (en) Tricyclic compounds as cgmp-pde inhibitors
FR2462161A1 (fr) Compositions therapeutiques a base de composes azoiques
BE1001262A4 (fr) Procede en vue de provoquer la regression de la leucemie et l'inhibition de la croissance des tumeurs chez les mammiferes.
BE862346R (fr) Nouveaux derives d'acides penicillanique et leur utilisation therapeutique
JPS6026113B2 (ja) ベンゾジアゼピン誘導体の製造法
BE882414A (fr) Nouveaux acides et esters 4-amino-3-quinoleine-carboxyliques, utiles notamment comme agents antisecretoires et anti-ulcere
JPS61236724A (ja) 抗けいれん組成物